Id Reaction (Autoeczematization)

Back

Practice Essentials

Id reaction, or autoeczematization, is a generalized acute cutaneous reaction to a variety of stimuli, including infectious and inflammatory skin conditions. The pruritic rash that characterizes the id reaction, which is considered immunologic in origin, has been referred to as dermatophytid,[1]  pediculid,[2]  bacterid (when associated with a corresponding infectious process), and tuberculid (when associated with tuberculosis).[3]  Noninfectious etiologies include stasis dermatitis, dyshidrotic eczema, medications and topical creams, tattoo ink, sutures, and radiotherapy.[4]

 Clinical and histopathologic manifestations are variable and depend on the etiology of the eruption, and systemic manifestations may occur.[5, 6, 7]  (See the image below.)



View Image

Id reaction (autoeczematization). Image from DermNet New Zealand (http://www.dermnetnz.org/assets/Uploads/dermatitis/a-ecz2.jpg).

Pathophysiology

While the exact cause of the id reaction is unknown, the following factors are thought to be responsible: (1) abnormal immune recognition of autologous skin antigens, (2) increased stimulation of normal T cells by altered skin constituents,[8, 9] (3) lowering of the irritation threshold, (4) dissemination of infectious antigen with a secondary response, and (5) hematogenous dissemination of cytokines from a primary site. Some cases have been related to medications and intravenous immune globulin (IVIG).[10] Id reaction has also been noted with bacille Calmette-Guérin (BCG) therapy.[11]

Etiology

The etiology of id reactions includes the following:

With the growing popularity of tattoos, id reactions to red tattoo ink have been increasingly noted, as well as an id reaction reported following laser tattoo removal.[17, 18]  Neosporin was found to be the trigger for an id reaction in an immunocompromised patient.[19]

No consensus has been reached on whether papulonecrotic tuberculid[20]   represents a true hypersensitivity reaction rather than the result of a local cutaneous tuberculosis infection because of the identification (by polymerase chain reaction) of Mycobacterium tuberculosis in some lesions.[7, 21]   

Epidemiology

The exact prevalence of id reaction is not known. Dermatophytid reactions are reported to occur in 4-5% of patients with dermatophyte infections. Id reactions have been reported in up to 37% of patients with stasis dermatitis. Furthermore, an estimated two thirds of patients with contact dermatitis superimposed on stasis dermatitis develop an id reaction.

Predilections according to age group are unknown but are influenced by the primary cause of the reaction. The condition has no known predilection for either sex. The condition has no known predilection for any racial or ethnic group.

Prognosis

Prognosis is good once the inciting etiology has been identified and appropriately treated. Morbidity results from symptoms of the id reaction and the acute onset of the primary eruption.

History

Id reactions result from a variety of stimuli, including infectious entities and inflammatory skin conditions. Dermatologic manifestations vary and depend on the etiology of the eruption. General history may include the following:

Physical Examination

Clinical lesions of id reactions are quite variable and are largely predicated on the inciting etiology. Lesions are, by definition, at a site distant from the primary infection or dermatitis. They are usually distributed symmetrically. Clinical forms include the following:

Laboratory Studies

Laboratory workup of id reactions (autoeczematization) is clearly indicated for dermatophytids (id reactions from dermatophytes). Strict criteria include a proven dermatophyte infection and a positive skin test finding for a group-specific trichophytin antigen. Absence of fungi in the dermatophytid lesions and clearing of the dermatophytid after the fungus is eradicated are necessary to confirm a definitive diagnosis of a dermatophytid reaction. Laboratory investigations require suspicion of the underlying cause and must be designed accordingly, as in the case of syphilid or tuberculid.

Other Tests

Patch testing may be needed to exclude primary or secondary allergic contact dermatitis.

Procedures

Biopsy for routine hematoxylin and eosin staining may be helpful in excluding noneczematous dermatoses, which may appear morphologically similar to an id reaction.

Histologic Findings

Histopathologic evaluation of the typical papulovesicular lesion reveals a superficial perivascular lymphohistiocytic infiltrate with a spongiotic epidermis, often with vesiculation. Small numbers of eosinophils may be present in the dermal infiltrate. By definition, infectious agents should not be found in the specimens.

Medical Care

The goal of medical care is adequate treatment of the underlying infection or dermatitis, which should lead to prompt resolution of the id reaction (autoeczematization). Recurrences are common, especially if the primary source is not treated adequately. The id reaction itself can be treated with topical steroids, systemic steroids, or antihistamines, but such treatment should not be instituted before infectious causes are eradicated.

 

 

Complications

Complications can include secondary infection resulting from excoriation, as well as secondary allergic contact dermatitis from topically applied medicaments or emollients and the use of medications targeting etiologies and symptoms.

Consultations

If a severe underlying infection is present, consultation with an infectious disease specialist or an internist is warranted.

Amcinonide (Cyclocort)

Clinical Context: 

Fluocinonide (Lidemol, Lidex, Lyderm)

Clinical Context: 

Prednisone (Deltasone, Prednisone Intensol, Rayos)

Clinical Context: 

Methylprednisolone (A-Methapred, DepoMedrol, Medrol)

Clinical Context: 

Diphenhydramine (Alka-Seltzer Plus Allergy, Benadryl, Benadryl Allergy Dye-Free LiquiGels)

Clinical Context: 

Loratadine (Alavert, Claritin, Claritin RediTabs)

Clinical Context: 

What is id reaction (autoeczematization)?What is the pathophysiology of id reaction (autoeczematization)?What is the prevalence of id reaction (autoeczematization)?What is the prognosis of id reaction (autoeczematization)?What causes id reaction (autoeczematization)?Which history is characteristic of id reaction (autoeczematization)?Which physical findings are characteristic of id reaction (autoeczematization)?What are the differential diagnoses for Id Reaction (Autoeczematization)?What is the role of lab studies in the evaluation of id reaction (autoeczematization)?What is the role of patch testing in the evaluation of id reaction (autoeczematization)?What is the role of biopsy in the evaluation of id reaction (autoeczematization)?Which historical findings are characteristic of id reaction (autoeczematization)?What is included in the medical care for id reaction (autoeczematization)?What are possible complications of id reaction (autoeczematization)?Which specialist consultations are needed for the treatment of id reaction (autoeczematization)?Which medications in the drug class Corticosteroids, Topical are used in the treatment of Id Reaction (Autoeczematization)?Which medications in the drug class Corticosteroids are used in the treatment of Id Reaction (Autoeczematization)?

Author

Edward J Zabawski, Jr, DO, MBA, Adjunct Assistant Professor, Clinical Sciences

Disclosure: Nothing to disclose.

Specialty Editors

Richard P Vinson, MD, Assistant Clinical Professor, Department of Dermatology, Texas Tech University Health Sciences Center, Paul L Foster School of Medicine; Consulting Staff, Mountain View Dermatology, PA

Disclosure: Nothing to disclose.

Jeffrey P Callen, MD, Professor of Medicine (Dermatology), Chief, Division of Dermatology, University of Louisville School of Medicine

Disclosure: Received income in an amount equal to or greater than $250 from: Biogen US (Adjudicator for study entry cutaneous lupus erythematosus); Priovant (Adjudicator for entry into a dermatomyositis study); IQVIA (Serono - adjudicator for a study of cutaneous LE) <br/>Received honoraria from UpToDate for author/editor; Received royalty from Elsevier for book author/editor; Received dividends from trust accounts, but I do not control these accounts, and have directed our managers to divest pharmaceutical stocks as is fiscally prudent from Stock holdings in various trust accounts include some pharmaceutical companies and device makers for these trust accounts for: Stocks held in various trust accounts: Allergen; Amgen; Pfizer; 3M; Johnson and Johnson; Merck; Abbott Laboratories; AbbVie; Procter and Gamble;; Celgene; Gilead; CVS; Walgreens; Bristol-Myers Squibb.

Chief Editor

Dirk M Elston, MD, Professor and Chairman, Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina College of Medicine

Disclosure: Nothing to disclose.

Additional Contributors

Darryl Bronson, MD, MPH, Consultant and Immediate Past Chairman, Division of Dermatology, Department of Medicine, Cook County Hospital of Chicago; Instructor, Department of Dermatology, University of Illinois at Chicago

Disclosure: Nothing to disclose.

Donald Belsito, MD, Professor of Clinical Dermatology, Department of Dermatology, Columbia University Medical Center

Disclosure: Nothing to disclose.

Matthew P Evans, MD, Chair, Department of Dermatology, Dreyer Medical Clinic

Disclosure: Nothing to disclose.

References

  1. Brown A. To itch, perchance to scratch. Clin Pediatr (Phila). 2009 Apr. 48 (3):334. [View Abstract]
  2. Brenner S, Ophir J, Krakowski A. Pediculid. An unusual -id reaction to pediculosis capitis. Dermatologica. 1984. 168 (4):189-91. [View Abstract]
  3. Chao SC, Lee YP, Lee JY. Eosinophilic cellulitis and panniculitis with generalized vesicular pustular id reaction after a molten aluminum burn. Dermatitis. 2010 May-Jun. 21 (3):E11-5. [View Abstract]
  4. Bertoli MJ, Schwartz RA, Janniger CK. Autoeczematization: A Strange Id Reaction of the Skin. Cutis. 2021 Sep. 108 (3):163-166. [View Abstract]
  5. Singh PY, Sinha P, Baveja S, Sood A. Immune-mediated tuberculous uveitis - A rare association with papulonecrotic tuberculid. Indian J Ophthalmol. 2019 Jul. 67 (7):1207-1209. [View Abstract]
  6. Kajal NC, Prasanth P, Dadra R. Lichen scrofulosorum: An uncommon manifestation of a common disease. Int J Mycobacteriol. 2020 Jul-Sep. 9 (3):313-315. [View Abstract]
  7. Kolalapudi SA, Konala S, Kotha S, Arumilli PC, Kalagarla S. Unusual presentations of cutaneous tuberculosis. Indian J Tuberc. 2020 Jul. 67 (3):433-437. [View Abstract]
  8. Cunningham MJ, Zone JJ, Petersen MJ, Green JA. Circulating activated (DR-positive) T lymphocytes in a patient with autoeczematization. J Am Acad Dermatol. 1986 Jun. 14 (6):1039-41. [View Abstract]
  9. Kasteler JS, Petersen MJ, Vance JE, Zone JJ. Circulating activated T lymphocytes in autoeczematization. Arch Dermatol. 1992 Jun. 128 (6):795-8. [View Abstract]
  10. Brazzelli V, Grassi S, Savasta S, Ruffinazzi G, Carugno A, Barbaccia V, et al. Pompholyx of the hands after intravenous immunoglobulin therapy for clinically isolated syndrome: a paediatric case. Int J Immunopathol Pharmacol. 2014 Jan-Mar. 27 (1):127-30. [View Abstract]
  11. Lowther C, Miedler JD, Cockerell CJ. Id-like reaction to BCG therapy for bladder cancer. Cutis. 2013 Mar. 91 (3):145-6, 151. [View Abstract]
  12. Crum N, Hardaway C, Graham B. Development of an idlike reaction during treatment for acute pulmonary histoplasmosis: a new cutaneous manifestation in histoplasmosis. J Am Acad Dermatol. 2003 Feb. 48 (2 Suppl):S5-6. [View Abstract]
  13. Choudhri SH, Magro CM, Crowson AN, Nicolle LE. An Id reaction to Mycobacterium leprae: first documented case. Cutis. 1994 Oct. 54 (4):282-6. [View Abstract]
  14. Netchiporouk E, Cohen BA. Recognizing and managing eczematous id reactions to molluscum contagiosum virus in children. Pediatrics. 2012 Apr. 129 (4):e1072-5. [View Abstract]
  15. Lian J, Dundas G, Tron V, Lauzon G, Roa W. radiotherapy-induced ID reaction. Am J Clin Oncol. 2005 Feb. 28 (1):105-6. [View Abstract]
  16. Trattner A, David M. Tefillin dermatitis. J Am Acad Dermatol. 2005 May. 52 (5):831-3. [View Abstract]
  17. Price A, Tavazoie M, Meehan SA, Leger M. Id reaction associated with red tattoo ink. Cutis. 2018 Nov. 102 (5):E32-E34. [View Abstract]
  18. Wong IT, Cheung LW. Id reaction and allergic contact dermatitis post-picosecond laser tattoo removal: A case report. SAGE Open Med Case Rep. 2021. 9:2050313X211057934. [View Abstract]
  19. Bathla JS, Tur K, Sragi Z, Sugg K. Autosensitization Triggered by Neosporin Use: A Unique Phenomenon. Cureus. 2022 Jul. 14 (7):e26987. [View Abstract]
  20. Morrison JG, Fourie ED. The papulonecrotic tuberculide. From Arthus reaction to lupus vulgaris. Br J Dermatol. 1974 Sep. 91 (3):263-70. [View Abstract]
  21. Kaul S, Jakhar D, Mehta S, Singal A. Cutaneous tuberculosis. Part II: Complications, diagnostic workup, histopathologic features, and treatment. J Am Acad Dermatol. 2023 Dec. 89 (6):1107-1119. [View Abstract]
  22. Al Aboud K, Al Hawsawi K, Alfadley A. Tinea incognito on the hand causing a facial dermatophytid reaction. Acta Derm Venereol. 2003. 83 (1):59. [View Abstract]
  23. Gorgievska-Sukarovska B, Skerlev M, Žele-Starčević L, Husar K, Halasz M. Kerion Celsi due to Microsporum canis with a Dermatophytid Reaction. Acta Dermatovenerol Croat. 2017 Jul. 25 (2):151-154. [View Abstract]
  24. Atzori L, Pau M, Aste M. Erythema multiforme ID reaction in atypical dermatophytosis: a case report. J Eur Acad Dermatol Venereol. 2003 Nov. 17 (6):699-701. [View Abstract]

Id reaction (autoeczematization). Image from DermNet New Zealand (http://www.dermnetnz.org/assets/Uploads/dermatitis/a-ecz2.jpg).

Id reaction (autoeczematization). Image from DermNet New Zealand (http://www.dermnetnz.org/assets/Uploads/dermatitis/a-ecz2.jpg).